Newsfeeds - Spark Newswire

2 minute read

FDA
News

MyMD Pharmaceuticals Advances Phase 2 Multi-Center Clinical Trial of MYMD-1 As Therapy For Delaying Aging And Extending Healthy Lifespan

Today, 6:41 AM

MyMD Pharmaceuticals, Inc.® (NASDAQ:MYMD) ("MyMD" or "the Company"), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced further advancement in

MYMD

1 minute read

MyMD Pharmaceuticals Receives Decision To Grant European Patent Titled ‘Genetically Modified Cannabis Sativa Plants And Modified Cannabinoid Compounds For Treatment Of Substance Addiction And Other Disorders’

By Bill Haddad

Today, 6:41 AM

https://twitter.com/PatentGrants/status/1531687979588038656

MYMD

57 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 6:41 AM

On Friday, 1043 companies hit new 52-week lows.

AAOI

2 minute read

MyMD Pharmaceuticals, Inc. Announces Preclinical Study Data On MYMD-1 Showing ‘significantly greater anti-inflammatory effect than current TNF-alpha inhibitors on the market’

By Bill Haddad

Today, 6:41 AM

MyMD seeks to disrupt the $31 billion global market for rheumatoid arthritis (RA) drug therapies with MYMD-1, which could potentially prove safer, more effective and better tolerated than current

MYMD

2 minute read

FDA
News

MyMD Pharmaceuticals Enrolls First Patient In Phase 2 Clinical Trial Of MYMD-1

By Benzinga Newsdesk

Today, 6:41 AM

MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) ("MyMD" or "the Company"), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that the first patient has

MYMD

3 minute read

News

MyMD Pharmaceuticals Highlights Investment Company Oravax Medical’s Cooperation And Purchase Agreement For Initial Pre-Purchase Of 10M Doses Of Oral COVID-19 Vaccine To Be Commercialized In Southeast Asia

By Bill Haddad

Today, 6:41 AM

In addition to pre-purchase order, parties have agreed to negotiate potential follow-on orders that could be significant MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) ("MyMD" or "the Company"), a

MYMD

4 minute read

51 Biggest Movers From Yesterday

By Lisa Levin

Today, 6:41 AM

Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares climbed 65.1% to close at $8.95 on Monday after the company announced a strategic collaboration with Stryker Corporation to develop the LIBERTY robotic system for neurovascular applications.

AERI

1 minute read

Events
News

MyMD Pharma To Discusses Its Novel Therapies For Aging, Related Diseases At Dawson James Small Cap Growth Conference Thursday, Oct. 21 at 4:30 p.m. EDT

By Benzinga Newsdesk

Today, 6:41 AM

MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, announced today that it will present at the

MYMD

1 minute read

Cramer Likes Azek And SoFi, But Said Owning This Stock Could Be Dreadful

By Craig Jones

Today, 6:41 AM

On CNBC's "Mad Money Lightning Round," Jim Cramer said MyMD Pharmaceuticals Inc (NASDAQ: MYMD) is very speculative and one needs to be gutsy to buy it.

AZEK

3 minute read

Benzinga Announces The 8 ‘Rising Star’ Companies Being Featured On Its Next ‘All Access’ Show

By Spencer Israel

Today, 6:41 AM

Benzinga is thrilled to announce the guest lineup for our next All Access show, set to air Thursday, October 7 at 9:00 am ET.

BTCY